Skip to Content
cncpt-artikel_lb_atf

Pneumococcal Vaccination of Patients with Autoimmune Inflammatory Rheumatic Diseases

Pneumococcal vaccination might prevent the risk of serious pneumococcal infection in patients with autoimmune inflammatory rheumatic diseases (AIIRD). However, a study of the antibody response in patients with AIIRD showed that only 36% achieved a protective antibody level after pneumococcal vaccination.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top